Browse > Article

Effect of MBCP block as carrier of rhBMP-2 in combination with ePTFE membrane on bone formation in rat calvarial defects  

Shin, Chul-Woo (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Cho, Kyoo-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Jung, Sung-Won (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Chang-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Choi, Seong-Ho (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University)
Yun, Jeong-Ho (Department of Dentistry, College of Medicine, Kwandong University, Myongji Hospital)
Publication Information
Journal of Periodontal and Implant Science / v.38, no.sup2, 2008 , pp. 325-334 More about this Journal
Abstract
Purpose: The carrier used as delivery agent for bone morphogenetic proteins(BMPs) should also act as a scaffold for new bone formation. Moreover, bone formation should be predictable in terms of the volume and shape. This study examined the osteogenic effect of macroporous biphasic calcium phosphate (MBCP) block combined with ePTFE membrane as a carrier for recombinant human bone morphogenetic proteins (rhBMP-2). In addition, the additive effect of ePTFE membrane on bone formation was evaluated. Materials and Methods: Eight-millimeter critical sized calvarial defects were created surgically in 28 male Sprague-Dawley rats. The animals were divided into 2 groups containing 14 animals each. The defects were treated with either rhBMP-2/MBCP block (rhBMP-2/MBCP group) or rhBMP-2/MBCP block/ePTFE membrane (rhBMP-2/MBCP/ePTFE group). A disc-shaped MBCP block (3 mm height and 8 mm diameter) was used as the carrier for the rhBMP-2 and ePTFE membrane was used to cover the rhBMP-2/MBCP block. The histologic and histometric parameters were used to evaluate the defects after 2- or 8-week healing period (7 animals/group/healing interval). Results: The level of bone formation in the defects of both groups was significantly higher at 8 weeks than that at 2 weeks (P < 0.05). The ePTFE membrane has no additional effect compared with the rhBMP-2/MBCP block only. However, at 8 weeks, rhBMP-2/MBCP/ePTFE group showed more even bone formation on the top of the MBCP block than the rhBMP-2/MBCP group. Conclusion: These results suggest that the ePTFE membrane has no additive effect on bone formation when a MBCP block is used as a carrier for rhBMP-2.
Keywords
rhBMP-2; MBCP block; ePTFE membrane; carrier;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hyun SJ, Choi SH, Chai JK, et al. The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-1674.   DOI   ScienceOn
2 Lindholm TS, Gao TJ. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol Suppl 1993;207:3-12.   PUBMED
3 Jung UW, Choi SY, Pang EK, et al. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2006;77: 765-772.   DOI   ScienceOn
4 Han DK, Kim CS, Jung UW, et al. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-2222.   DOI   ScienceOn
5 Hong SJ, Kim CS, Han DK, et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816.   DOI   ScienceOn
6 Nery EB, LeGeros RZ, Lynch KL, Lee K. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/ß-TCP in periodontal osseous defects. J Periodontol 1992;63:729-735.   DOI   PUBMED
7 Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunins. Clin Orthop Relat Res 1986;205:299-308.   PUBMED
8 Daculsi G, Passuti N, Martin S, et al. Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res 1990;24:379-396.   DOI   PUBMED   ScienceOn
9 Zellin G, Linde A. Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials. 1996;17:695-702.   DOI   ScienceOn
10 Wikesjo UM, Xiropaidis AV, Thomson RC, et al. Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS-induced bone formation. J Clin Periodontol 2003;30:715-725.   DOI   ScienceOn
11 Miranda DA, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjo UM. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 2005;76:210-220.   DOI   ScienceOn
12 Le Nihouannen D, Daculsi G, Saffarzadeh A, et al. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone 2005;36:1086-1093.   DOI   ScienceOn
13 Linde A, Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive ePTFE membranes: an experimental study in rats. Calcif Tissue Int 1995;56:549-553.   DOI   ScienceOn
14 Scantlebury TV. 1982-1992: a decade of technology development for guided tissue regeneration. J Periodontol. 1993;64:1129-1137.   DOI   PUBMED   ScienceOn
15 Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899.   DOI   PUBMED   ScienceOn
16 Habibovic P, Yuan H, van den Doel M, et al. Relevance of osteoinductive biomaterials in critical-sized orthotopic defect. J Orthop Res 2006;24:867-876.
17 LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 2003;14:201-209.   DOI   ScienceOn
18 Zellin G, Hedner E, Linde A. Bone regeneration by a combination of osteopromotive membranes with different BMP preparations: a review. Connect Tissue Res 1996;35:279-284.   DOI   ScienceOn
19 Manjubala I, Sastry TP, Kumar RV. Bone in-growth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl 2005;19:341-360.   DOI   ScienceOn
20 Wikesjo UM, Lim WH, Thomson RC, Hardwick WR. Periodontal repair in dogs: gingival tissue occlusion, a critical requirement for GTR J Clin Periodontol. 2003;30: 655-664.   DOI   ScienceOn
21 Ahn SH, Kim CS, Suk HJ, et al. Effect of recombinant human bone morphogenetic protein- 4 with carriers in rat calvarial defects. J Periodontol 2003;74:787-797.   DOI   ScienceOn
22 Zellin G, Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res 1997;35: 181-190.   DOI   ScienceOn
23 Polimeni G, Koo KT, Qahash M, et al. Prognostic factors for alveolar regeneration: effect of tissue occlusion on alveolar bone regeneration with guided tissue regeneration. J Clin Periodontol. 2004;31:730-735.   DOI   ScienceOn
24 Linde A, Alberius P, Dahlin C, Bjurstam K, Sundin Y. Osteopromotion: a soft tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontol 1993;64:1116-1128.   DOI   PUBMED   ScienceOn
25 Aldinger G, Herr G, Kusswetter W, et al. Bone morphogenetic protein: a review. Int Orthop 1991;15: 169-177.   PUBMED
26 Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 1998;19:133-139.   DOI   ScienceOn
27 Lee YJ, Jung SW, Chae GJ Cho KS, Kim CS. The effect of recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system on bone formation in rat calvarial defects. J Kor Acad Periodontol 2007;37:397-407.   DOI
28 Gordh M, Alberius P, Johnell O, Lindberg L, Linde A. Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting. Plast Reconstr Surg 1999;103: 1909-1918.   DOI   ScienceOn
29 Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-2677.   DOI   ScienceOn
30 Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26;2501-2507.   DOI   ScienceOn
31 Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72.   DOI   ScienceOn
32 Cordaro L, Amade DS, Cordaro M. Clinical results of alveolar ridge augmentation with mandibular block bone grafts in partially edentulous patients prior to implant placement. Clin Oral Implants Res 2002;13:103-111.   DOI   ScienceOn